Vous êtes sur la page 1sur 56

DEPARTMENT OF TECHNICAL EDUCATION ANDRA PRADESH

Name of the Staff Designation : Y.Venkat Reddy : Sr. Lecturer

Branch
Institute Subject Subject Code Topic Sub topic Duration Teaching Aid

: Packaging Technology
: J.N.G.P.Ramanthapur,Hyd : Drug & Pharmaceutical Packaging : PKG.503 : Introduction to Drug Packaging : Basic concept of Drug & its terminology : 100 minutes : PPT, Animations & Photographs
PKG-503.3 TO 4 1

Recap

In the last class we have learnt about


The Concept of Drug and its related Terminology

PKG-503.3 TO 4

Objectives:
On the completion of the topic the student will able to understand

The Concept Classification of Pharmaceuticals.

Preparation of Tablets.

PKG-503.3 TO 4

Classification
The pharmaceuticals can be classified under two broad categories viz. 1. Sterile and

2.

Non- sterile

PKG-503.3 TO 4

The

former

includes

parenteral

preparations

and

ophthalmic preparations

and under the latter comes orals, products for external


use such as ointments, lotions, liniments and

suppositories.

PKG-503.3 TO 4

From the view point of packaging , the drugs could be broadly divided into following categories Solids Tablets, Granules, Capsules Liquid Orals Syrups, Suspensions

PKG-503.3 TO 4

Skin ointments, cream and lotions


Eye ointments , lotions and creams Parenteral preparations (injections)

Sterile powders, solutions/ suspensions,

Sterilized surgical catguts and sutures

PKG-503.3 TO 4

The pharmaceuticals can also be classified into two broad categories Orals Injectables

PKG-503.3 TO 4

The 'Oral' form of pharmaceuticals comprises of


1. Powders and granules 2. Tablets (coated and uncoated)

3. Soft and hard gelatin capsules and lozenges


4. Syrups / drops / liquids

PKG-503.3 TO 4

The Injectable form of pharmaceuticals comprises of


Powder form injectables
Liquid form injectables

Intravenous (I.V) Fluids

PKG-503.3 TO 4

10

selection of the new drug's most effective route of administration: oral parenteral (i.e. injection into body cavity) transdermal (i.e., through skin) rectal

vaginal

PKG-503.3 TO 4

11

Available dosage forms


1. SOLID
i. powder ii. capsules iii. tablets

2. LIQUID
i. solution ii. suspension iii. emulsion
PKG-503.3 TO 4 12

3. SEMI-SOLID
i. ointments

ii. creams

4. MISCELLANEOUS
i. inhalants

ii. aerosols

PKG-503.3 TO 4

13

Powders
Powder preparation involves two processes the isolation of coarse, aggregated substances and the reduction of particle size.

PKG-503.3 TO 4

14

Microencapsulated Powders
Micro encapsulation, the coating of very small solid particles or liquid droplets, is done Sterile Powders for Injection Some pharmaceuticals for injection are supplied as powders because of instability in solution. These are dissolved in water just prior to use.

PKG-503.3 TO 4

15

Tablets
Tablets are made in a variety of shapes.

Sizes
depends

and

weights
on the

amount of drug in the


dose and the mode of

administration.

PKG-503.3 TO 4

16

They are prepared by compression or molding. Compressed Tablet


Compressed tablets are made by compaction of powdered
or granular substances.

Un-coated Immediate Release

PKG-503.3 TO 4

17

Layered
Tablet Within a Tablet
Two Part Three Layer

Compression Coated Function as Film/Sugar


Coated

PKG-503.3 TO 4

18

Film Coated

Solvent Based
Aqueous Based Alternative to Sugar Coated

PKG-503.3 TO 4

19

INGREDIENTS Active Drug Substance

Non-Active Diluents Binders Lubricants Disintegrants Coloring Flavoring Antiadherents


PKG-503.3 TO 4 20

Pharmaceutical solutions:
One of more solvent to dissolve the drug Preservatives to prevent microbial growth Stabilizers to prevent drug decomposition

Colorants and flavorants to enhance product appeal

PKG-503.3 TO 4

21

Drug Substance
Fully Characterized Physical Specifications (Including Particle size distribution, density, isomerism

and Morphology)

Chemical

Specifications

(Including

Impurity

and

Degradation Profile)

PKG-503.3 TO 4

22

DILUENTS:

Diluents or filler to increase the bulk of the formulation.


Lactose Starch

Mannitol
Calcium Sulfate Sorbitol

Dicalcium Phosphate
Kaolin Sodium Chloride Powdered Sugar Microcrystalline Cellulose
PKG-503.3 TO 4 23

DISINTEGRANTS
Disintegrating agents to promote tablet break up after

administration
Starch Micro-crystaline Cellulose Alginic Acid Gums Crospovidone
PKG-503.3 TO 4 24

Binders
Binders to cause the adhesion of the powdered drug and inactive ingredients

Starch Paste Glucose Gelatin Solution Acacia

Sucrose
Sodium Alginate
PKG-503.3 TO 4 25

LUBRICANTS
Antiadherents or lubricants to assist the smooth tableting process Magnesium Stearate Calcium Stearate

Talc
Stearic Acid

Sodium Lauryl Sulfate


Sodium Acetate
PKG-503.3 TO 4 26

The manufacturing process consists of two basic steps


mixing of ingredients,

and compaction into a tablet.


The most widely used mixing methodwet granulation

the active drug and additives are first blended in large


scale blenders such as twin-shell rotary blenders, stirred

vessels, and fluidized beds.

PKG-503.3 TO 4

27

GRANULATING

Wet Granulation
Direct Compression Dry Granulation Slugging Roll Compaction

PKG-503.3 TO 4

28

Wet Granulation
Advantages Improved Compressibility

Improved uniformity
Decreased segregation Flexibility Process complexity Cost

Disadvantages

Possible affect on drug


substance
PKG-503.3 TO 4 29

PKG-503.3 TO 4

30

Dry Granulation
Useful when ingredients are sensitive to moisture or heat.
Blended ingredients are either compressed into slugs or
roll compacted into sticks or sheets

Slugs or sticks are screened/milled


Granulation is blended with lubricant an disintegrants then

compressed

PKG-503.3 TO 4

31

PKG-503.3 TO 4

32

Direct Compression

Ingredients are milled and/or screened, then mixed, then

compressed into tablets.


Few Manufacturing steps

Greater potential for segregation

PKG-503.3 TO 4

33

High speed Rotary Press


PKG-503.3 TO 4 34

Tablets making by compression

a) Fill

b) Corrected fill

c) Compression
PKG-503.3 TO 4

d) Ejection
35

Molded Tablets

Molded tablets are

prepared to achieve rapid


dissolution in water.

PKG-503.3 TO 4

36

Mixers & Blenders


Pony/Planetary Mixer High Shear Mixer Ribbon Blender Screw Blender Tumble Blenders Twin Shell Double Cone Drums Other

PKG-503.3 TO 4

37

PKG-503.3 TO 4

38

PKG-503.3 TO 4

39

PKG-503.3 TO 4

40

PKG-503.3 TO 4

41

COATING
Protect drug from the environment Mask taste Improve appearance Separate ingredients Provide multiple release profiles

PKG-503.3 TO 4

42

COATING Equipment

Standard coating pan

Perforated coating pan Fluidized bed

PKG-503.3 TO 4

43

Standard Pans

PKG-503.3 TO 4

44

Tablet bed Pan coater with immersion tube


PKG-503.3 TO 4 45

Drum coater for Tablets

PKG-503.3 TO 4

46

Standard Pans

PKG-503.3 TO 4

47

Perforated Pans

PKG-503.3 TO 4

48

Fluid Bed

PKG-503.3 TO 4

49

Fluidized bed coater

Air
PKG-503.3 TO 4 50

Film Coating Materials


Polymers - Hydroxypropyl methylcellulos Povidone Polyethyleneglycol Enteric Materials - Cellulose acetate phthalate Sugar Coating Materials Sealant - Shellac Sugar - Syrup and color
PKG-503.3 TO 4 51

Summary
PREFERABLE DOSAGE FORMS:
When the medication is intended for systemic use and oral administration is desired: *tablet *capsules *oral solutions or suspensions

PKG-503.3 TO 4

52

When the medications intended for infants and children under 5 years of age: *liquid preparations when immediate therapeutic action is desired:

* injections

PKG-503.3 TO 4

53

Quiz
1.

Which of the following does not belongs to

solid form medication


a) Powder

b)
c)

capsules
emulsion

d)

tablets
PKG-503.3 TO 4 54

Quiz
2. When immediate therapeutic action is desired we use
a) Tablet b) capsules c) injections d) creams
PKG-503.3 TO 4 55

Frequently Asked Questions


1. How the pharmaceutical products are classified on the basis of Dosage forms ? 2. What are the different types of Tablet shapes ?

3.
4.

What are the basic ingredients of a Drug?


How the different types of pharmaceutical products are

manufactured ?
PKG-503.3 TO 4 56

Vous aimerez peut-être aussi